EVOLVE-HBV: Collection of materials for a study investigating epidemiology, clinical and laboratory features of Hepatitis B Virus (HBV) in South Africa
Domaine:
healthcareType de record:
dataset
Créateur:
MatAndSukUpt
Éditeur:
fig
Hôte:
This collection unifies materials from the Evaluation of Vukuzazi LiVEr disease - Hepatitis B "EVOLVE-HBV" study.
This project is an inter-disciplinary collaboration between the Africa Health Research Institute (AHRI), KwaZulu Natal, South Africa, and the Francis Crick Institute, London, UK, studying hepatitis B virus infection.
The study has ethics approval from the University of KwaZulu Natal (UKZN) Biomedical Research Ethics Committee (BREC) (ref. 00004495/2022) and University College London ethics committee in the UK (ref. 23221/001 EVOLVE-HBV).
This project is an inter-disciplinary collaboration between the Africa Health Research Institute (AHRI), KwaZulu Natal, South Africa, and the Francis Crick Institute, London, UK, studying hepatitis B virus infection.
The study has ethics approval from the University of KwaZulu Natal (UKZN) Biomedical Research Ethics Committee (BREC) (ref. 00004495/2022) and University College London ethics committee in the UK (ref. 23221/001 EVOLVE-HBV).
Similaires
Hepatitis B Virus (HBV) Risk Assessment — GhanaProtocol for EVOLVE-HBV, a study to determine the prevalence and characteristics of chronic hepatitis B virus infection in KwaZulu-Natal, South Africa, to inform interventions for diagnosis, treatment and preventionA study of knowledge, experience and beliefs about hepatitis B virus (HBV) infection in south western UgandaEpidemiological patterns of hepatitis B virus (HBV) in highly endemic areasrEVOLVE HBV Project: Logistical Challenges, Acceptability, and Service Development for HBV Care in South Africa. Report of a team dialogue and feedback event.Screening, characterisation and prevention of Hepatitis B virus (HBV) co-infection in HIV-positive children in South Africa